UACA Antibody

UACA (uveal autoantigen with coiled-coil domains and ankyrin repeats) was originally identified as an autoantigen in patients with panuveitis, a characteristic of Vogt-Koyanagi-Harada disease, and in patients with Graves’ disease. UACA was also later identified as Nucling, an mRNA differentially expressed in F9 embryonal carcinoma cells during cardiac muscle differentiation. UACA appears to function as a pro-apoptotic protein that recruits the apaf-1-pro-caspase-9 complex for the induction of apoptosis to mediate the cell-death pathway.
UACA
uveal autoantigen with coiled-coil domains and ankyrin repeats
Uveal autoantigen with coiled-coil domains and ankyrin repeats
:  FLJ10128 KIAA1561 nuclear membrane binding protein nucling uveal autoantigen with coiled coil domains and ankyrin repeats
Product
Specifications
Ordering Information
Human
IP, IHC-P
Between 1 and 50
$339
$99
Human
IP, IHC-P
Between 675 and 725
$339
$99
Human, Mouse, Rat
WB, IP
Between 1075 and 1125
$339
$229
$99
Human, Mouse, Rat
Includes: 1 each of A301-381A, A301-382A and A301-383A
$707
Includes: 1 each of A301-381A, A301-382A and A301-383A
Human
IHC-P
Between 675 and 725
$360
$99